|1.||Cruz, M E M: 2 articles (12/2014 - 03/2012)|
|2.||Almeida, A J: 2 articles (12/2014 - 03/2012)|
|3.||Eleutério, C V: 2 articles (12/2014 - 03/2012)|
|4.||Paredez, Alexander R: 2 articles (11/2008 - 08/2008)|
|5.||Roberts, A V: 2 articles (11/2007 - 11/2003)|
|6.||Pereira, J: 1 article (12/2014)|
|7.||Carvalheiro, M: 1 article (12/2014)|
|8.||Gaspar, M M: 1 article (12/2014)|
|9.||Lopes, R M: 1 article (12/2014)|
|10.||Takahata, Yoshihito: 1 article (12/2013)|
12/01/2013 - "When haploids were treated with oryzalin for chromosome doubling, diploids and tetraploids were obtained. "
11/01/2007 - "In treatments with 5 microM oryzalin, the frequencies of tetraploid and mixoploid leaves were lower, at equivalent exposure times, in 10 mm nodes than 2 mm nodes. "
11/01/2007 - "Fewer tetraploid and mixoploid leaves were found when 2 mm nodes were exposed to 2.5 microM oryzalin for 6 and 12 h, indicating that it took longer for a spindle inhibiting concentration of oryzalin to build up in the meristem. "
11/01/2007 - "The frequency of tetraploid and mixoploid leaves that developed from 2 mm nodal sections exposed to 5 microM oryzalin peaked at 12 h exposure, when 35% of the leaves were tetraploid, but fell after longer exposures. "
11/01/2003 - "Thin (1 mm) nodal sections were treated with 5 microM oryzalin and the highest frequency of tetraploids (66%) was obtained after exposure for only 1 day. "
10/01/2012 - "Oryzalin (ORZ) is a dinitroaniline that has attracted increasing interest for the treatment of leishmaniasis. "
03/12/2012 - "Oryzalin is a dinitroaniline drug that has attracted recent interest for the treatment of leishmaniasis. "
03/12/2012 - "Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis."
12/01/2014 - "Liposomes versus lipid nanoparticles: comparative study of lipid-based systems as oryzalin carriers for the treatment of leishmaniasis."
11/18/2008 - "The pfd6-1 mutant exhibits a range of microtubule defects, including hypersensitivity to oryzalin, defects in cell division, cortical array organization, and microtubule dynamicity. "
11/18/2008 - "By screening for oryzalin hypersensitivity, we identified several mutants of Arabidopsis that have lesions in PFD subunits. "
08/01/2008 - "To identify factors that influence cytoskeletal organization we screened for Arabidopsis (Arabidopsis thaliana) mutants that show hypersensitivity to the microtubule destabilizing drug oryzalin. "
09/01/1993 - "The upA12 mutation caused twofold resistance to amiprophos-methyl and oryzalin, and twofold hypersensitivity to the microtubule-stabilizing drug taxol, suggesting that the mutation enhanced microtubule stability. "
08/29/1997 - "N-Depropyloryzalin caused similar inhibition of colony formation by HT-29 colon cancer cells as oryzalin with IC50 = 8 micrograms/ml. The results suggest that oryzalin and its N-depropyl metabolite can inhibit tumor colony formation at pharmacologically achievable levels."
01/01/1997 - "Oryzalin inhibited colony formation of HT-29 colon carcinoma cells with an IC50 of 8 microM and inhibited the growth of a number of other cancer cell lines and primary human tumors in vitro with IC50 values in the range 3 to 22 microM. "
01/01/1997 - "Oryzalin at doses up to 600 mg/kg administered orally or subcutaneously daily to mice for 3 to 10 days beginning a day after tumor inoculation inhibited the growth of murine B16 melanoma by 63% but showed no appreciable activity when administered subcutaneously or intraperitoneally to mice beginning a number of days after tumor inoculation against a variety of human tumor xenografts. "
10/01/2002 - "Pretreatment of cysts with oryzalin for 30 min in phosphate-buffered saline markedly reduced viability and prevented excystation in growth medium with or without the drug. "
10/01/2002 - "Excystation and metacystic development were further inhibited when the cysts were incubated for 30 min in encystation medium containing oryzalin before transfer to growth medium with the drug. "
10/01/2002 - "When cysts were incubated for 1 day in growth medium plus oryzalin, little increase in the number of metacystic amoebae was observed after removal of the drug. "
10/01/2002 - "The effect of oryzalin on excystation and metacystic development of Entamoeba invadens strain IP-1 was examined by transfer of cysts to a growth medium containing the drug. "
08/01/2000 - "When cysts prepared at day 1 of encystation, most of which were mononucleate, were reincubated in the presence of oryzalin for an additional 2 days, inhibition of their maturation was observed. "
|1.||Heterologous Transplantation (Xenotransplantation)